DATE: SUBJECT:
JUNE 7, 2019
GTX, INC. ? REVERSE SPLIT AND NAME/SYMBOL/CUSIP CHANGE
OPTION SYMBOL: GTXI
NEW SYMBOL: ONCT1
DATE: 6/10/19
GTx, Inc. (GTXI) has announced a 1-for-7 reverse stock split and a name/symbol/CUSIP change. As a result of the reverse stock split and name/symbol/CUSIP change, each GTXI Common Share will be converted into the right to receive approximately 0.142857 (New) Oncternal Therapeutics, Inc. (ONCT) Common Shares. The reverse stock split and name/symbol/CUSIP change will become effective before the market open on June 10, 2019.
NOTE: GTx, Inc. has declared a dividend of one (1) non-transferable contingent value right (CVR) to shareholders of record on Friday, June 7, 2019. The GTXI option deliverable will NOT be adjusted to include the non-transferable CVR.
CONTRACT ADJUSTMENT
#45165
Effective Date: Option Symbol:
Contract Multiplier:
Strike Divisor: New Multiplier:
New Deliverable Per Contract:
CUSIP:
June 10, 2019
GTXI changes to ONCT1
1
1
100 (e.g., for premium or strike dollar extensions 1.00 will equal $100)
1) 14 (New) Oncternal Therapeutics, Inc. (ONCT) Common Shares 2) Cash in lieu of approximately 0.2857 fractional ONCT Shares
Note: The GTXI option deliverable will not be adjusted to include the non-transferable Contingent Value Right.
ONCT (New): 68236P107
PRICING
Until the cash in lieu amount is determined, the underlying price for ONCT1 will be determined as follows: ONCT1 = 0.142857 (ONCT)
DELAYED SETTLEMENT
The ONCT component of the ONCT1 deliverable will settle through National Securities Clearing Corporation (NSCC). OCC will delay settlement of the cash portion of the ONCT1 deliverable until the cash in lieu of fractional ONCT Shares is determined. Upon determination of the cash in lieu amount, OCC will require Put exercisers and Call assignees to deliver the appropriate cash amount.
DISCLAIMER
This Information Memo provides an unofficial summary of the terms of corporate events affecting listed options or futures prepared for the convenience of market participants. OCC accepts no responsibility for the accuracy or completeness of the summary, particularly for information which may be relevant to investment decisions. Option or futures investors should independently ascertain and evaluate all information concerning this corporate event(s).
The determination to adjust options and the nature of any adjustment is made by OCC pursuant to OCC By-Laws, Article VI, Sections 11 and 11A. The determination to adjust futures and the nature of any adjustment is made by OCC pursuant to OCC By-Laws, Article XII, Sections 3, 4, or 4A, as applicable. For both options and futures, each adjustment decision is made on a case by case basis. Adjustment decisions are based on information available at the time and are subject to change as additional information becomes available or if there are material changes to the terms of the corporate event(s) occasioning the adjustment.
ALL CLEARING MEMBERS ARE REQUESTED TO IMMEDIATELY ADVISE ALL BRANCH OFFICES AND CORRESPONDENTS ON THE ABOVE.
For questions regarding this memo, call Investor Services at 1-888-678-4667 or email investorservices@theocc.com. Clearing Members may contact Member Services at 1-800-544-6091 or, within Canada, at 1-800-424-7320, or email memberservices@theocc.com.
